Tartrate-resistant acid phosphatase 5b, but not periostin, is useful for assessing Paget's disease of bone
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Additive Genetic Effects on Circulating Periostin Contribute to the Heritability of Bone MicrostructureThe Journal of Clinical Endocrinology & Metabolism, 2015
- Bone turnover markers in Paget’s disease of the bone: A Systematic review and meta-analysisOsteoporosis International, 2015
- Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formationRheumatology, 2014
- New developments in biological markers of bone metabolism in osteoporosisBone, 2014
- Serum Periostin Is Associated With Fracture Risk in Postmenopausal Women: A 7-Year Prospective Analysis of the OFELY StudyThe Journal of Clinical Endocrinology & Metabolism, 2014
- A single infusion of zoledronic acid produces sustained remissions in paget disease: Data to 6.5 yearsJournal of Bone and Mineral Research, 2011
- Recombinant Osteoprotegerin for Juvenile Paget's DiseaseNew England Journal of Medicine, 2005
- Non-Isomerized C-Telopeptide Fragments Are Highly Sensitive Markers for Monitoring Disease Activity and Treatment Efficacy in Paget's Disease of BoneJournal of Bone and Mineral Research, 2005
- Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's diseaseJournal of Bone and Mineral Research, 1995
- Clinical usefulness of serum tartrate-resistant acid phosphatase activity determination to evaluate bone turnoverScandinavian Journal of Clinical and Laboratory Investigation, 1991